midodrine has been researched along with Depression in 4 studies
Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byun, JI | 1 |
| Moon, J | 1 |
| Kim, DY | 1 |
| Shin, H | 1 |
| Sunwoo, JS | 1 |
| Lim, JA | 1 |
| Kim, TJ | 1 |
| Lee, WJ | 1 |
| Lee, HS | 1 |
| Jun, JS | 1 |
| Park, KI | 1 |
| Lee, ST | 1 |
| Jung, KH | 1 |
| Jung, KY | 1 |
| Kim, M | 1 |
| Lee, SK | 1 |
| Chu, K | 1 |
| Tang, C | 1 |
| Yu, R | 1 |
| Gracie, J | 1 |
| Newton, JL | 1 |
| Norton, M | 1 |
| Baker, C | 1 |
| Freeston, M | 1 |
| Jörg, J | 1 |
1 trial available for midodrine and Depression
| Article | Year |
|---|---|
Delayed orthostatic hypotension: Severity of clinical symptoms and response to medical treatment.
Topics: Cross-Sectional Studies; Depression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; H | 2018 |
3 other studies available for midodrine and Depression
| Article | Year |
|---|---|
Adult-onset idiopathic isolated central hypothyroidism: a case report and literature review.
Topics: Adrenergic alpha-1 Receptor Agonists; Antidepressive Agents, Second-Generation; Depression; Female; | 2015 |
The role of psychological factors in response to treatment in neurocardiogenic (vasovagal) syncope.
Topics: Adaptation, Psychological; Adult; Aged; Anxiety; Cross-Sectional Studies; Depression; Fear; Female; | 2006 |
[Therapeutic concept in Parkinson disease].
Topics: Adrenergic beta-Antagonists; Amantadine; Antidepressive Agents, Tricyclic; Benzodiazepines; Bromocri | 1983 |